|
COG6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.88409998292639E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84930000038486E-07 |
| Normal-vs-Stage2 |
1.800130E-03 |
| Normal-vs-Stage3 |
2.8391999862265E-09 |
| Normal-vs-Stage4 |
3.75259999740862E-08 |
| Stage1-vs-Stage2 |
5.709000E-01 |
| Stage1-vs-Stage3 |
4.850200E-02 |
| Stage1-vs-Stage4 |
9.266500E-02 |
| Stage2-vs-Stage3 |
7.762300E-02 |
| Stage2-vs-Stage4 |
9.766400E-02 |
| Stage3-vs-Stage4 |
8.726200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35699995684746E-09 |
| Normal-vs-AfricanAmerican |
7.335800E-03 |
| Normal-vs-Asian |
1.76340999999969E-05 |
| Caucasian-vs-AfricanAmerican |
2.595800E-01 |
| Caucasian-vs-Asian |
9.035400E-01 |
| AfricanAmerican-vs-Asian |
3.851400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.25729998318769E-09 |
| Normal-vs-Female |
1.01270000052445E-07 |
| Male-vs-Female |
1.425610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.06149999995675E-06 |
| Normal-vs-Age(41-60Yrs) |
4.67130000236793E-08 |
| Normal-vs-Age(61-80Yrs) |
7.46160000453244E-08 |
| Normal-vs-Age(81-100Yrs) |
1.056470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.066200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.420220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.099400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.875600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.178400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.637200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.241400E-01 |
| Classical-VS-Follicular |
5.861400E-01 |
| Classical-VS-Other |
3.687200E-01 |
| Classical-VS-Normal |
8.64889999618867E-08 |
| Tall-VS-Follicular |
1.253430E-01 |
| Tall-VS-Other |
7.611800E-01 |
| Tall-VS-Normal |
3.40080000005294E-06 |
| Follicular-VS-Other |
3.582200E-01 |
| Follicular-VS-Normal |
3.231400E-04 |
| Other-VS-Normal |
4.137600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38199999946787E-07 |
| Normal-vs-N1 |
2.18290000519872E-08 |
| N0-vs-N1 |
1.374600E-01 |
|
|
